Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine
Aim: This study aimed to evaluate the prevalence of obstructive sleep apnea (OSA) and its correlates among schizophrenia spectrum disorder patients receiving clozapine. Methods: For this, 200 schizophrenia spectrum disorder patients receiving clozapine for at least one year were assessed on the Berl...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Indian Journal of Psychiatry |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_544_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556797874241536 |
|---|---|
| author | Rika Rijal Sandeep Grover Subho Chakrabarti Swapnajeet Sahoo |
| author_facet | Rika Rijal Sandeep Grover Subho Chakrabarti Swapnajeet Sahoo |
| author_sort | Rika Rijal |
| collection | DOAJ |
| description | Aim:
This study aimed to evaluate the prevalence of obstructive sleep apnea (OSA) and its correlates among schizophrenia spectrum disorder patients receiving clozapine.
Methods:
For this, 200 schizophrenia spectrum disorder patients receiving clozapine for at least one year were assessed on the Berlin Sleep Questionnaire for OSA.
Results:
Around one-sixth of the study sample (16.5%) had a high risk for OSA at a body mass index (BMI) cut-off of 30 kg/m2. When a BMI cut-off of 25 kg/m2 was used, the prevalence of OSA was 36%. A high risk for OSA is associated with a higher prevalence of depression, a higher number of psychiatric comorbidities, diabetes mellitus, a higher mean total chlorpromazine equivalent dose, a higher number of total medications, poorer quality of life in some of the domains, and scored high for all domains and the total score of UKU.
Conclusion:
To conclude, this study suggests that a high risk of OSA is associated with the presence of depression, a higher number of psychiatric comorbidities, diabetes mellitus, use of higher total chlorpromazine equivalent dose, the total number of medications, poorer quality of life, and a higher prevalence of other side effects. |
| format | Article |
| id | doaj-art-720b633dfb4b45278a565f652d64f820 |
| institution | Kabale University |
| issn | 0019-5545 1998-3794 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Psychiatry |
| spelling | doaj-art-720b633dfb4b45278a565f652d64f8202025-01-07T06:32:29ZengWolters Kluwer Medknow PublicationsIndian Journal of Psychiatry0019-55451998-37942024-12-0166121159116410.4103/indianjpsychiatry.indianjpsychiatry_544_24Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapineRika RijalSandeep GroverSubho ChakrabartiSwapnajeet SahooAim: This study aimed to evaluate the prevalence of obstructive sleep apnea (OSA) and its correlates among schizophrenia spectrum disorder patients receiving clozapine. Methods: For this, 200 schizophrenia spectrum disorder patients receiving clozapine for at least one year were assessed on the Berlin Sleep Questionnaire for OSA. Results: Around one-sixth of the study sample (16.5%) had a high risk for OSA at a body mass index (BMI) cut-off of 30 kg/m2. When a BMI cut-off of 25 kg/m2 was used, the prevalence of OSA was 36%. A high risk for OSA is associated with a higher prevalence of depression, a higher number of psychiatric comorbidities, diabetes mellitus, a higher mean total chlorpromazine equivalent dose, a higher number of total medications, poorer quality of life in some of the domains, and scored high for all domains and the total score of UKU. Conclusion: To conclude, this study suggests that a high risk of OSA is associated with the presence of depression, a higher number of psychiatric comorbidities, diabetes mellitus, use of higher total chlorpromazine equivalent dose, the total number of medications, poorer quality of life, and a higher prevalence of other side effects.https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_544_24clozapineobstructive sleep apneaside effects |
| spellingShingle | Rika Rijal Sandeep Grover Subho Chakrabarti Swapnajeet Sahoo Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine Indian Journal of Psychiatry clozapine obstructive sleep apnea side effects |
| title | Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine |
| title_full | Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine |
| title_fullStr | Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine |
| title_full_unstemmed | Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine |
| title_short | Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine |
| title_sort | prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long term clozapine |
| topic | clozapine obstructive sleep apnea side effects |
| url | https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_544_24 |
| work_keys_str_mv | AT rikarijal prevalenceandfactorsassociatedwithhighriskforobstructivesleepapneainschizophreniaspectrumdisorderpatientsonlongtermclozapine AT sandeepgrover prevalenceandfactorsassociatedwithhighriskforobstructivesleepapneainschizophreniaspectrumdisorderpatientsonlongtermclozapine AT subhochakrabarti prevalenceandfactorsassociatedwithhighriskforobstructivesleepapneainschizophreniaspectrumdisorderpatientsonlongtermclozapine AT swapnajeetsahoo prevalenceandfactorsassociatedwithhighriskforobstructivesleepapneainschizophreniaspectrumdisorderpatientsonlongtermclozapine |